Reuters logo
BRIEF-Marinus Pharmaceuticals qtrly loss per share $0.15‍​
October 31, 2017 / 11:39 AM / in 24 days

BRIEF-Marinus Pharmaceuticals qtrly loss per share $0.15‍​

Oct 31 (Reuters) - Marinus Pharmaceuticals Inc

* Marinus Pharmaceuticals provides business update and reports third quarter 2017 financial results

* Marinus Pharmaceuticals Inc - ‍“believes” cash, cash equivalents and investments as of Sept 30, 2017 are adequate to fund operations into 2020​

* Marinus Pharmaceuticals Inc qtrly loss per share $0.15‍​

* Marinus-Initiating Phase 2 feasibility study with ganaxolone iv in patients with refractory status epilepticus, data expected in 2018‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below